Pacific Biosciences of California (PACB) Set to Announce Earnings on Tuesday
Pacific Biosciences of California (NASDAQ:PACB) is scheduled to be releasing its Q313 earnings data on Tuesday, October 22nd. Analysts expect Pacific Biosciences of California to post earnings of ($0.30) per share and revenue of $7.08 million for the quarter.
Pacific Biosciences of California (NASDAQ:PACB) last issued its quarterly earnings data on Thursday, August 1st. The company reported ($0.33) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.35) by $0.02. The company had revenue of $6.04 million for the quarter, compared to the consensus estimate of $6.09 million. During the same quarter in the prior year, the company posted ($0.40) earnings per share. The company’s quarterly revenue was down 17.1% on a year-over-year basis.
Shares of Pacific Biosciences of California (NASDAQ:PACB) traded up 0.19% during mid-day trading on Monday, hitting $5.30. The stock had a trading volume of 351,653 shares. Pacific Biosciences of California has a 52 week low of $1.06 and a 52 week high of $6.50. The stock’s 50-day moving average is $4.52 and its 200-day moving average is $3.20. The company’s market cap is $345.8 million.
On the ratings front, analysts at Maxim Group raised their price target on shares of Pacific Biosciences of California from $4.00 to $8.00 in a research note to investors on Thursday, September 26th. They now have a “buy” rating on the stock.
Pacific Biosciences, Inc develops Deoxyribonucleic Acid (NASDAQ:PACB) sequencing platform.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.